NCT06653803 Rhomboid Intercostal Block Versus Retrolaminar Block for Postoperative Analgesia After Thoracoscopic Sympathectomy
| NCT ID | NCT06653803 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Damanhour Teaching Hospital |
| Condition | Post Operative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-08-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: Although thoracoscopic sympathectomy is made via small incisions, it is associated with severe postoperative pain. Both Rhomboid intercostal block (RIB) and Retrolaminar block (RLB) are recent techniques used for pain control after such procedures Objectives: To compare the effectiveness of RIB and RLB in providing postoperative analgesia after thoracoscopic sympathectomy in adult patients and their impact on the patient's outcomes. Patients and Methods: This prospective, randomized (1:1), double-blind clinical trial; will be carried out on 60 patients scheduled for elective thoracoscopic sympathectomy under general anesthesia at our hospital. Patients will be randomly allocated into two equal groups (30 patients each) and will receive: in group A; general anesthesia with intraoperative ipsilateral ultrasound-guided RIB, whereas in group B; general anesthesia with intraoperative ipsilateral ultrasound-guided RLB.
Eligibility Criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) physical status ≤ II * Age from 18 to 60 years * Body Mass Index (BMI) \< 35 kg/m² Exclusion Criteria: * American Society of Anesthesiologists (ASA) physical status \> II * Age \< 18 years or \> 60 years * Body Mass Index (BMI) ≥ 35 * Local infection at the puncture site * Altered mental status * Pregnant women * Allergy to study drugs * Chronic pain * Coagulation abnormalities or on anticoagulants * Severe hepatic or kidney disease
Contact & Investigator
Ahmed M Shaat, MD
PRINCIPAL INVESTIGATOR
Damanhour Teaching Hospital
Frequently Asked Questions
Who can join the NCT06653803 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Post Operative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06653803 currently recruiting?
Yes, NCT06653803 is actively recruiting participants. Contact the research team at ahmedshaat99@gmail.com for enrollment information.
Where is the NCT06653803 trial being conducted?
This trial is being conducted at Damanhūr, Egypt.
Who is sponsoring the NCT06653803 clinical trial?
NCT06653803 is sponsored by Damanhour Teaching Hospital. The principal investigator is Ahmed M Shaat, MD at Damanhour Teaching Hospital. The trial plans to enroll 60 participants.